We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Influenza A Virus: Cellular Entry

    The frequent emergence of pathogenic viruses with pandemic potential has posed a significant threat to human health and economy, despite enormous...
    Yasuyuki Miyake, Yuya Hara, ... Indranil Banerjee in Virus Infected Cells
    Chapter 2023
  2. Evaluation of the fully automated, sample-to-result Seegene STARlet-AIOS platform for detection of SARS-CoV-2, influenza virus A, influenza virus B, and RSV

    Early, accurate, and bulk detection of respiratory pathogens is essential for patient management and infection control. STARlet-All-in-One System...

    C.W.E. Brouwer, A. Russcher, ... R.H.T. Nijhuis in European Journal of Clinical Microbiology & Infectious Diseases
    Article 15 November 2023
  3. A mosaic influenza virus-like particles vaccine provides broad humoral and cellular immune responses against influenza A viruses

    The development of a universal influenza vaccine to elicit broad immune responses is essential in reducing disease burden and pandemic impact. In...

    Xuejie Liu, Tianyi Zhao, ... Yuelong Shu in npj Vaccines
    Article Open access 07 September 2023
  4. Influenza A Virus Neuraminidase Inhibitors

    Depending on the strain, influenza A virus causes animal, zoonotic, pandemic, or seasonal influenza with varying degrees of severity. Two surface...
    Nongluk Sriwilaijaroen, Christopher J. Vavricka, ... Yasuo Suzuki in Glycovirology
    Protocol 2022
  5. Defining the balance between optimal immunity and immunopathology in influenza virus infection

    Influenza A viruses remain a global threat to human health, with continued pandemic potential. In this Review, we discuss our current understanding...

    Thi H. O. Nguyen, Louise C. Rowntree, ... Katherine Kedzierska in Nature Reviews Immunology
    Article 02 May 2024
  6. Attenuation of A(H7N9) influenza virus infection in mice exposed to cigarette smoke

    Influenza A(H7N9) virus showed high pathogenicity in humans when it emerged in 2013. Cigarette smoke (CS) causes pulmonary diseases including...

    Satoshi Fukuyama, Jason E. Shoemaker, ... Yoshihiro Kawaoka in npj Viruses
    Article Open access 25 March 2024
  7. Clinical characteristics of outpatients with influenza-B-associated pneumonia and molecular evolution of influenza B virus in Bei**g, China, during the 2021–2022 influenza season

    We analyzed the clinical characteristics of outpatients with influenza-B-associated pneumonia during the 2021–2022 influenza season and analyzed the...

    Yanxin Wang, Yafen Liu, ... Yan Gao in Archives of Virology
    Article Open access 18 January 2024
  8. Influenza Virus Entry inhibitors

    Influenza is a major challenge to health and the global economy. However, the increasing emergence of drug resistance during influenza pandemics...
    Jie Yang, Shuwen Liu in Virus Entry Inhibitors
    Chapter 2022
  9. A small molecule compound targeting hemagglutinin inhibits influenza A virus and exhibits broad-spectrum antiviral activity

    Influenza A virus (IAV) is a widespread pathogen that poses a significant threat to human health, causing pandemics with high mortality and...

    Yin-yan Li, Guo-dong Liang, ... Jie Yang in Acta Pharmacologica Sinica
    Article 10 July 2024
  10. Expression of the SARS-CoV-2 receptor-binding domain by live attenuated influenza vaccine virus as a strategy for designing a bivalent vaccine against COVID-19 and influenza

    Influenza and SARS-CoV-2 are two major respiratory pathogens that cocirculate in humans and cause serious illness with the potential to exacerbate...

    Ekaterina Stepanova, Irina Isakova-Sivak, ... Larisa Rudenko in Virology Journal
    Article Open access 09 April 2024
  11. A protective measles virus-derived vaccine inducing long-lasting immune responses against influenza A virus H7N9

    A novel Influenza A virus (subtype H7N9) emerged in spring 2013 and caused considerable mortality in zoonotically infected patients. To be prepared...

    Cindy Hörner, Anna H. Fiedler, ... Michael D. Mühlebach in npj Vaccines
    Article Open access 24 March 2023
  12. Nanoparticle display of neuraminidase elicits enhanced antibody responses and protection against influenza A virus challenge

    Current Influenza virus vaccines primarily induce antibody responses against variable epitopes in hemagglutinin (HA), necessitating frequent updates....

    M. N. Pascha, M. Ballegeer, ... C. A. M. de Haan in npj Vaccines
    Article Open access 31 May 2024
  13. Effects and mechanism of Qingke **chuan granules against influenza virus infection

    Qingke **chuan granules (QPGs), which contain Houttuynia cordata Thunb, Fritillaria cirrhosa , fired licorice, and fired bitter almonds, among other...

    Linqing He, Jiarui Cao, ... Lingman Ma in Archives of Virology
    Article 28 May 2024
  14. Phillyrin ameliorates influenza a virus-induced pulmonary inflammation by antagonizing CXCR2 and inhibiting NLRP3 inflammasome activation

    Influenza is an acute viral respiratory illness with high morbidity rates worldwide. Excessive pulmonary inflammation is the main characteristic of...

    Shanyu Zhang, Fengzhi Sun, ... **aolong Wang in Virology Journal
    Article Open access 13 November 2023
  15. A novel film spray containing curcumin inhibits SARS-CoV-2 and influenza virus infection and enhances mucosal immunity

    Background

    Infection by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and influenza virus is still a major worldwide health concern....

    Wipawee Nittayananta, Hatairat Lerdsamran, ... Jaruta Kerdto in Virology Journal
    Article Open access 23 January 2024
  16. Cholesterol and M2 Rendezvous in Budding and Scission of Influenza A Virus

    The cholesterol of the host cell plasma membrane and viral M2 protein plays a crucial role in multiple stages of infection and replication of the...
    Jesper J. Madsen, Jeremy S. Rossman in Virus Infected Cells
    Chapter 2023
  17. H6N2 reassortant avian influenza virus isolate in wild birds in Jiangxi Province, China

    H6 avian influenza virus is widely prevalent in wild birds and poultry and has caused human infection in 2013 in Taiwan, China. During our active...

    Yingjie Wang, **ang Li, ... **angwei Zeng in Virus Genes
    Article 09 May 2024
  18. Advancing usability of an influenza hemagglutinin virus-like particle vaccine expressing a chimeric cytokine

    Vaccine efficacy of conventional influenza vaccines depend on the antigenic similarity between the selected vaccine strain and annual epidemic...

    Toshifumi Imagawa, Youta Arasaki, ... Kuniaki Nerome in Virology Journal
    Article Open access 26 May 2023
  19. Influenza from a One Health Perspective: Infection by a Highly Versatile Virus

    Influenza A viruses (IAVs) are among the most versatile viruses, in terms of host range, pathogenesis, route of transmission, transmissibility...
    Leslie A. Reperant, Albert D. M. E. Osterhaus in Zoonoses: Infections Affecting Humans and Animals
    Reference work entry 2023
  20. Immune response in influenza virus infection and modulation of immune injury by viral neuraminidase

    Influenza A viruses cause severe respiratory illnesses in humans and animals. Overreaction of the innate immune response to influenza virus infection...

    Hongyu Jiang, Zongde Zhang in Virology Journal
    Article Open access 28 August 2023
Did you find what you were looking for? Share feedback.